Suggested Posts for you
The Heart Team: Collaboration is key

A key focus of the new ESC/EACTS […]

5 Min

The Heart Team: Collaboration is key

October 5, 2021

A key focus of the new ESC/EACTS guidelines is the instrumental role of the Heart Team in decisions concerning intervention and treatment, and the importance of collaborative decision making, taking both the Heart Team’s expert guidance and the wishes of the patient into consideration.

Key points include:

29SEPT21_Colaboration icon_0-1

Heart Team recommendations must be discussed with patient and family to allow informed treatment choice

29SEPT21_Medical centre_0-1

Heart Valve Centres are a key component of the Heart Team approach

29SEPT21_decline_0-1

Early Heart Team referral encouraged if patient’s symptoms develop/worsen before next planned visit

29SEPT21_patient_0-1

All patients with severe aortic stenosis must be referred through the Heart Team

Joint decision making gets the right treatment to each patient

ESC/EACTS guidelines now recommend that an active and collaborative Heart Team make decisions about intervention and treatment.

Your expertise means you are best placed to recommend the optimal valve procedure for the patient, in collaboration with the other specialists and dedicated personnel of the Heart Team.

27SEPT21_Heart team diagram_WEB_0-1

Class I recommendations for a collaborative Heart Team approach

29SEPT21_Recomendations_0-1

The choice between a surgical or transcatheter approach will depend on evaluation of the clinical, anatomical and procedural factors by the Heart Team, considering the risks and benefits for each individual patient.

29SEPT21_Recomendations_0-1


Interventions should be performed in Heart Valve Centres, using a structured and collaborative Heart Team approach.

29SEPT21_Recomendations_0-1

All procedural decisions should be patient-centred, giving consideration to age, operative risk, the patient’s life expectancy, lifestyle and environmental factors, their potential for reintervention and any co-morbidities. The final recommendation should also consider the desires of the patient. Ensure you meet your patients’ high expectations by offering them the best valve technologies. Early referral is encouraged if a patient’s symptoms develop/worsen before the next planned visit.

All procedural decisions should be patient-centred, giving consideration to age, operative risk, the patient’s life expectancy, lifestyle and environmental factors, their potential for reintervention and any co-morbidities. The final recommendation should also consider the desires of the patient. Ensure you meet your patients’ high expectations by offering them the best valve technologies. Early referral is encouraged if a patient’s symptoms develop/worsen before the next planned visit.

Interested in finding out more

The upcoming EACTS Annual Meeting has several sessions relevant for these changes:

You can also read more practical information about the ESC/EACTS guidelines

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks or service marks of Edwards Lifesciences Corporation or its affiliates.  All other trademarks are the property of their respective owners.

© 2021 Edwards Lifesciences Corporation. All rights reserved. PP–EU-2918 v1.0

Edwards Lifesciences • Route de l’Etraz 70, 1260 Nyon, Switzerland • edwards.com